170 related articles for article (PubMed ID: 19960329)
1. Immunohistochemical detection of tumour hypoxia.
Young RJ; Möller A
Methods Mol Biol; 2010; 611():151-9. PubMed ID: 19960329
[TBL] [Abstract][Full Text] [Related]
2. Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.
Evans A; Bates V; Troy H; Hewitt S; Holbeck S; Chung YL; Phillips R; Stubbs M; Griffiths J; Airley R
Cancer Chemother Pharmacol; 2008 Mar; 61(3):377-93. PubMed ID: 17520257
[TBL] [Abstract][Full Text] [Related]
3. Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha.
Berlth F; Mönig SP; Schlösser HA; Maus M; Baltin CT; Urbanski A; Drebber U; Bollschweiler E; Hölscher AH; Alakus H
Anticancer Res; 2014 Jul; 34(7):3313-20. PubMed ID: 24982335
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical assessment of intrinsic and extrinsic markers of hypoxia in reproductive tissue: differential expression of HIF1α and HIF2α in rat oviduct and endometrium.
Gillies RM; Robinson SP; McPhail LD; Carter ND; Murray JF
J Mol Histol; 2011 Aug; 42(4):341-54. PubMed ID: 21732047
[TBL] [Abstract][Full Text] [Related]
5. No detectable hypoxia in malignant salivary gland tumors: preliminary results.
Wijffels KI; Hoogsteen IJ; Lok J; Rijken PF; Marres HA; de Wilde PC; van der Kogel AJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1319-25. PubMed ID: 18973979
[TBL] [Abstract][Full Text] [Related]
6. Improved immunohistochemical method for detecting hypoxia gradients in mouse tissues and tumors.
Samoszuk MK; Walter J; Mechetner E
J Histochem Cytochem; 2004 Jun; 52(6):837-9. PubMed ID: 15150293
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
8. Endogenous hypoxia markers: case not proven!
Mayer A; Höckel M; Vaupel P
Adv Exp Med Biol; 2008; 614():127-36. PubMed ID: 18290322
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of hypoxia in mouse liver tissues treated with pimonidazole using "in vivo cryotechnique".
Terada N; Ohno N; Saitoh S; Ohno S
Histochem Cell Biol; 2007 Sep; 128(3):253-61. PubMed ID: 17680263
[TBL] [Abstract][Full Text] [Related]
10. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
11. Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry.
Gulliksrud K; Vestvik IK; Galappathi K; Mathiesen B; Rofstad EK
Radiat Res; 2008 Nov; 170(5):638-50. PubMed ID: 18959463
[TBL] [Abstract][Full Text] [Related]
12. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
[TBL] [Abstract][Full Text] [Related]
13. Analysis of hypoxia-inducible factor 1alpha expression and its effects on invasion and metastasis.
Krishnamachary B; Semenza GL
Methods Enzymol; 2007; 435():347-54. PubMed ID: 17998062
[TBL] [Abstract][Full Text] [Related]
14. Investigation of possible endogenous hypoxia markers in colorectal cancer.
Verstraete M; Debucquoy A; Devos E; Sagaert X; Penninckx F; Begg A; Haustermans K
Int J Radiat Biol; 2013 Jan; 89(1):9-15. PubMed ID: 22852555
[TBL] [Abstract][Full Text] [Related]
15. Improved cryosections and specific immunohistochemical methods for detecting hypoxia in mouse and rat cochleae.
Donadieu E; Hamdi W; Deveze A; Lucciano M; Lavieille JP; Magnan J; Riva C
Acta Histochem; 2007; 109(3):177-84. PubMed ID: 17349680
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts.
Airley RE; Phillips RM; Evans AE; Double J; Burger AM; Feibig HH; West CM; Stratford IJ
Int J Oncol; 2005 Jun; 26(6):1477-84. PubMed ID: 15870859
[TBL] [Abstract][Full Text] [Related]
17. Pimonidazole adduct immunohistochemistry in the rat kidney: detection of tissue hypoxia.
Rosenberger C; Rosen S; Paliege A; Heyman SN
Methods Mol Biol; 2009; 466():161-74. PubMed ID: 19148611
[TBL] [Abstract][Full Text] [Related]
18. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
19. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
Airley R; Loncaster J; Davidson S; Bromley M; Roberts S; Patterson A; Hunter R; Stratford I; West C
Clin Cancer Res; 2001 Apr; 7(4):928-34. PubMed ID: 11309343
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
Airley RE; Mobasheri A
Chemotherapy; 2007; 53(4):233-56. PubMed ID: 17595539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
